Skip to Content

Press Releases

Date Title and Summary Additional Formats
Jan 20, 2020
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced that a new landmark study demonstrates the potential for Imaging Mass Cytometry™ (IMC™) on the Hyperion™ Imaging System
Jan 14, 2020
Fourth quarter preliminary revenue of $32.0-32.4 million Fiscal year preliminary revenue of $116.7-117.2 million Mass cytometry revenue increased approximately 23 percent for the full fiscal year SOUTH SAN FRANCISCO, Calif. , Jan. 14, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM)
Jan 13, 2020
Fluidigm microfluidics technology to fuel growth in genomics services SOUTH SAN FRANCISCO, Calif. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- MOgene, a leading provider of genomic and bioinformatic services in St. Louis , today announced it has selected Fluidigm’s (NASDAQ:FLDM) Advanta™ assays and
Dec 18, 2019
SOUTH SAN FRANCISCO , Dec. 18, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation  (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that The University of Michigan Protein Assembly Lab , a hub for collaborative
Dec 12, 2019
Competition Recognizes Employers with Exceptional HR Programs and Forward-Thinking Workplace Policies SOUTH SAN FRANCISCO, Calif. , Dec. 12, 2019 (GLOBE NEWSWIRE) -- Fluidigm Canada, a subsidiary of Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to
Dec 10, 2019
Delivering the Largest Commercially Available Collection of Pathologist‑Verified Antibodies for Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif. , Dec. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced
Dec 09, 2019
2019 Gold Award for Best New Product in Cell Biology Awarded to Fluidigm SOUTH SAN FRANCISCO, Calif. , Dec. 09, 2019 (GLOBE NEWSWIRE) -- BioInformatics Inc. , the leading research and advisory firm serving the life science tools market, recognized  Fluidigm (NASDAQ:FLDM) with the Gold Award for the
Nov 20, 2019
SOUTH SAN FRANCISCO, Calif. , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the pricing of $50 million aggregate principal amount of 5.25%
Nov 20, 2019
SOUTH SAN FRANCISCO, Calif. , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it intends to offer, subject to market conditions and other
Nov 13, 2019
SOUTH SAN FRANCISCO, Calif. , Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in the 31st Annual Piper